Poly(I:C) enhances mesenchymal stem cell control of myeloid cells from COVID-19 patients-Reference-Cited by-同舟云学术

Poly(I:C) enhances mesenchymal stem cell control of myeloid cells from COVID-19 patients

Published:2022-05 Issue:5 Volume:25 Page:104188
ISSN:2589-0042
Container-title:iScience
language:en
Short-container-title:iScience

Author:

Souza-Moreira Luciana,Tan Yuan,Wang Yan,Wang Jia-Pey,Salkhordeh Mahmoud,Virgo Jennifer,Florian Maria,Murray Aidan B.P.,Watpool Irene,McIntyre Lauralyn,English Shane,Stewart Duncan J.,Mei Shirley H.J.^ORCID

Funder

Ottawa Hospital

Ontario Institute for Regenerative Medicine

Publisher

Elsevier BV

Subject

Multidisciplinary

Reference48 articles.

1. Targeting potential drivers of COVID-19: neutrophil extracellular traps;Barnes;J. Exp. Med.,2020

2. Safety and efficacy of multipotent adult progenitor cells in acute respiratory distress syndrome (MUST-ARDS): a multicentre, randomised, double-blind, placebo-controlled phase 1/2 trial;Bellingan;Intensive Care Med.,2022

3. Neutralizing monoclonal antibodies for the treatment and prophylaxis of SARS-CoV-2 infection;Bruzzesi;New Microbiol.,2021

4. Cytofkit: a bioconductor package for an integrated mass cytometry data analysis pipeline;Chen;PLoS Comput. Biol.,2016

5. A distinct innate immune signature marks progression from mild to severe COVID-19;Chevrier;Cell Rep. Med.,2021

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CEACAM1-engineered MSCs have a broad spectrum of immunomodulatory functions and therapeutic potential via cell-to-cell interaction;Biomaterials;2024-12

2. Key quality parameter comparison of mesenchymal stem cell product cryopreserved in different cryopreservation solutions for clinical applications;Frontiers in Bioengineering and Biotechnology;2024-08-01

3. TLR3 Agonist Amplifies the Anti‐Inflammatory Potency of ADSCs via IL‐10‐Mediated Macrophage Polarization in Acute Pancreatitis;Stem Cells International;2024-01

4. Mesenchymal stem cells induce dynamic immunomodulation of airway and systemic immune cells in vivo but do not improve survival for mice with H1N1 virus-induced acute lung injury;Frontiers in Bioengineering and Biotechnology;2023-06-08

5. Interleukin-18-primed human umbilical cord-mesenchymal stem cells achieve superior therapeutic efficacy for severe viral pneumonia via enhancing T-cell immunosuppression;Cell Death & Disease;2023-01-28